Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization

Molecular and Cellular Biology

Volumn 20, Issue 3, 2000, Pages 741-748

  Nie, Ying ^a   Li, Heng Hong ^a   Bula, Craig M ^a   Liu, Xuan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE; ONCOPROTEIN; PROTEIN P53; PROTEIN TYROSINE KINASE; TETRAMER;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DELETION MUTANT; DNA DAMAGE; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA; DNA-BINDING PROTEINS; MACROMOLECULAR SUBSTANCES; MUTAGENESIS, SITE-DIRECTED; OLIGONUCLEOTIDE PROBES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN STRUCTURE, QUATERNARY; PROTO-ONCOGENE PROTEINS C-ABL; RECOMBINANT PROTEINS; SEQUENCE DELETION; SPODOPTERA; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033985661     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.3.741-748.2000     Document Type: Article

References (35)

1. Franz, W. M., P. Berger, and J. Y. J. Wang. 1989. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8:137-147.
2. Glass, C. K. 1994. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev. 15:391-407.
3. Goga, A., X. Liu, T. M. Hambuch, K. Senechal, E. Mayor, A. J. Berk, O. N. Witte, and C. L. Sawyers. 1995. p53-dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11:791-799.
4. Gu, W., and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606.
5. Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71:875-886.
6. Hupp, T. R., A. Sparks, and D. P. Lane. 1995. Small peptide activate the latent sequence-specific DNA binding function of p53. Cell 83:237-245.
7. Jackson, P., and D. Baltimore. 1989. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8:449-456.
8. Jayaraman, L., K. G. K. Murthy, C. Zhu, T. Curran, S. Xanthoudakis, and C. Prives. 1997. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 11:558-570.
9. Jiang, G., U. Lee, and F. M. Sladek. 1997. Proposed mechanism for the stabilization of nuclear receptor DNA binding via protein dimerization. Mol. Cell. Biol. 17:6546-6554.
10. Kharbanda, S., Z. M. Yuan, R. Weichselbaum, and D. Kufe. 1998. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene 17:3309-3318.
11. Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
12. Konopka, J. B., and O. N. Witte. 1985. Detection of c-Abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol. Cell. Biol. 5:3116-3123.
13. Levine, A. J. 1997. p53, the cellular gatekeeper for the growth and division. Cell 88:323-331.
14. Liu, X., C. W. Miller, H. P. Koeffler, and A. J. Berk. 1993. The p53 activation domain binds the TATA box-binding polypeptide in holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol. Cell. Biol. 13:3291-3300.
15. Liu, X., and A. J. Berk. 1995. Reversal of in vitro p53 squelching by both TFIIB and TFIID. Mol. Cell. Biol. 15:6474-6478.
16. Liu, Z. G., R. Baskaran, E. T. Lea-Chou, L. D. Wood, Y. Chen, M. Karin, and J. Y. J. Wang. 1996. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384:273-276.
17. Liu, L., D. M. Scolnick, R. C. Trievel, H. B. Zhang, R. Marmorstein, T. D. Halazonetis, and S. L. Berger. 1999. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19:1202-1209.
18. Maki, C. G. 1999. Oligomerization is required for p53 to be efficiently ubiquitinated by Mdm2. J. Biol. Chem. 274:16531-16535.
19. Maver, B. J., and D. Baltimore. 1994. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell. Biol. 14:2883-2894.
20. McLure, K. G., and P. W. Lee. 1998. How p53 binds DNA as a tetramer. EMBO J. 17:3342-3350.
21. Pendergast, A. M., A. J. Muller, M. H. Havlik, Y. Maru, and O. N. Witte. 1991. BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL Sh2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66:161-171.
22. Pietenpol, J. A., T. Tokino, S. Thiagalingam, W. S. Ei-Deiry, K. W. Kinzler, and B. S. Vogelstein. 1994. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 91:1998-2002.
23. Prives, C. 1998. Signaling to p53: breaking the Mdm2-p53 circuit. Cell 95: 5-8.
24. Sheppard, H. M., S. I. Corneillie, C. Espiritu, and X. Liu. 1999. New insight into the mechanism of inhibition of p53 by simian virus 40 large T antigen. Mol. Cell. Biol. 19:2746-2753.
25. Shieh, S.-Y., Y. Taya and C. Prives. 1999. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J. 18:1815-1823.
26. Sionov, R. V., E. Moallem, M. Berger, A. Kazaz, O. Gerlitz, Y. Ben-Neriah, M. Oren, and Y. Haupt. 1999. C-Abl neutralizes the inhibitory effect of Mdm2 on p53. J. Biol. Chem. 274:8371-8374.
27. Sladek, F. M., D.-Y. Qing, and L. Nepomuceno. 1998. MODY1 mutation Q268X in hepatocyte nuclear factor 4a allows for dimerization in solution but cause abnormal subcellular localization. Diabetes 47:985-990.
28. Stürzbecher, H. W., B. R. Addison, C. Rudge, K. Hemm, M. Grimaldi, M. Keenan, and E. Jenkins, Jr. 1992. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene 7:1513-1523.
29. Unger, T., J. A. Mietz, M. Scheffner, C. L. Yee, and P. Howley. 1993. Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol. Cell. Biol. 13:5186-5194.
30. Van Etten, R. A., J. Debnath, H. Zhou, and J. M. Casasnovas. 1995. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro. Oncogene 10:1977-1988.
31. Waterman, M. J. F., E. S. Stavridi, J. L. F. Waterman, and T. D. Halazonetis. 1998. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19:175-178.
32. Yuan, Z. M., Y. Huang, M. M. Fan, C. L. Sawyers, S. Kharbanda, and D. Kufe. 1996. Genotoxic drugs induce interaction of the c-Abl tyrosine kinase and the tumor suppressor protein p53. J. Biol. Chem. 271:26457-26460.
33. Yuan, Z. M., Y. Huang, Y. Whang, C. L. Sawyers, R. Weichselbaum, S. Kharbanda, and D. Kufe. 1996. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature 382:272-274.
34. Yuan, Z. M., Y. Huang, T. Ishiko, S. Makada, T. Utsugisawa, H. Shioya, R. Weichselbaum, Y. Shi, and D. Kufe. 1999. Role for p300 in stabilization of p53 in the response to DNA damage. J. Biol. Chem. 274:1883-1886.
35. Yuan, Z. M., H. Shioya, T. Ishiko, X. Sun, J. Gu, Y. Y. Huang, H. Lu, S. Kharbanda, R. Weichselbaum, and D. Kufe. 1999. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399:814-817.